BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37196217)

  • 41. Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.
    Koka R; Bade NA; Sausville EA; Ning Y; Zou Y
    Mol Cytogenet; 2017; 10():39. PubMed ID: 29093755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin.
    Lukes J; Potuckova E; Sramkova L; Stary J; Starkova J; Trka J; Votava F; Zuna J; Zaliova M
    Genes Chromosomes Cancer; 2018 Sep; 57(9):471-477. PubMed ID: 29726059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.
    Shiraz P; Payne KJ; Muffly L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235787
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Heatley SL; Asari K; Schutz CE; Leclercq TM; McClure BJ; Eadie LN; Hughes TP; Yeung DT; White DL
    Leuk Lymphoma; 2021 May; 62(5):1157-1166. PubMed ID: 33390067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
    Brown LM; Hediyeh-Zadeh S; Sadras T; Huckstep H; Sandow JJ; Bartolo RC; Kosasih HJ; Davidson NM; Schmidt B; Bjelosevic S; Johnstone R; Webb AI; Khaw SL; Oshlack A; Davis MJ; Ekert PG
    Blood Adv; 2022 Apr; 6(7):2373-2387. PubMed ID: 35061886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.
    Wells J; Jain N; Konopleva M
    Clin Adv Hematol Oncol; 2017 Jul; 15(7):554-561. PubMed ID: 28749919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant.
    Samra B; Kantarjian HM; Sasaki K; Alotaibi AS; Konopleva M; O'Brien S; Ferrajoli A; Garris R; Nunez CA; Kadia TM; Short NJ; Jabbour E
    Acta Haematol; 2021; 144(3):285-292. PubMed ID: 33238261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
    Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of a cryptic
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
    Bassan R; Rohatiner AZ; Lerede T; Di Bona E; Rambaldi A; Pogliani E; Rossi G; Fabris P; Morandi S; Casula P; Carter M; Lambertenghi-Deliliers G; Lister TA; Barbui T
    Hematol J; 2000; 1(4):226-34. PubMed ID: 11920195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 68-Year-Old Man with a Cytogenetic Diagnosis of Chronic Myeloid Leukemia and Bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the JAK2 Gene.
    Warsi A; Alamoudi S; Alsuraihi AK; Althobaiti M; Daghistani M; Samarin K; Alahmadi MO; Abuyabis RG; Bogari RA; Filimban SA
    Am J Case Rep; 2023 Mar; 24():e938488. PubMed ID: 36864712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
    Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
    Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia.
    Hunger SP
    Hematology Am Soc Hematol Educ Program; 2011; 2011():361-5. PubMed ID: 22160058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.
    Schwab C; Harrison CJ
    Hemasphere; 2018 Aug; 2(4):e53. PubMed ID: 31723781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.
    Tsujimoto SI; Nakano Y; Osumi T; Okada K; Ouchi-Uchiyama M; Kataoka K; Fujii Y; Ohki K; Seki M; Tamagawa N; Takita J; Ogawa S; Kiyokawa N; Hara J; Kato M
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e397-e399. PubMed ID: 29219890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase inhibition.
    Xiao X; Liu P; Li D; Xia Z; Wang P; Zhang X; Liu M; Liao L; Jiao B; Ren R
    J Hematol Oncol; 2020 Jun; 13(1):80. PubMed ID: 32552902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article.
    Alghandour R; Sakr DH; Shaaban Y
    Ann Hematol; 2023 Jun; 102(6):1287-1300. PubMed ID: 37129698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.